This Article Full Text Full Text (PDF) All Versions of this Article: 108/2/211    most recent 01.CIR.0000079311.39939.94v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maggi, A. Articles by Puglisi, L. Search for Related Content PubMed PubMed Citation Articles by Maggi, A. Articles by Puglisi, L. Related Collections Angiogenesis Animal models of human disease Other Vascular biology

(Circulation. 2003;108:211.)
© 2003 American Heart Association, Inc.

Basic Science Reports

Diabetes Undermines Estrogen Control of Inducible Nitric Oxide Synthase Function in Rat Aortic Smooth Muscle Cells Through Overexpression of Estrogen Receptor-ß

Adriana Maggi, PhD^*; Andrea Cignarella, PhD^*; Alessia Brusadelli, PhD; Chiara Bolego, PhD; Christian Pinna, PhD; Lina Puglisi, PhD

From the Department of Pharmacological Sciences and Center of Excellence on Neurodegenerative Disease (A.M., A.B.), University of Milan, Italy.

Correspondance to Prof Adriana Maggi, Center of Excellence on Neurodegenerative Disease, Via Balzaretti 9, 20133 Milan, Italy. E-mail adriana.maggi{at}unimi.it

Background— Previous reports from our group have shown that 17ß-estradiol reduces the synthesis and activity of inducible nitric oxide synthase (iNOS) in rat aortic smooth muscle cells (SMC) in response to inflammatory mediators. In this study, we investigated the effect of 17ß-estradiol on iNOS function in aortic SMC from streptozotocin-diabetic rats.

Methods and Results— Comparative analysis of NO release and of iNOS mRNA and protein content after 24-hour stimulation with a cytokine mixture revealed milder iNOS activation in diabetic than in control SMC. Furthermore, 17ß-estradiol dose-dependently blocked iNOS synthesis and activity in control but not in diabetic SMC. The defective estrogen response in diabetic SMC at 24 hours could not be attributed to reduced expression of estrogen receptors (ER). In fact, mRNA and protein levels of ER and, to a greater extent, of ERß, were increased in diabetic compared with nondiabetic SMC. Cytokines decreased ER and ERß expression in both groups. However, 17ß-estradiol dose-dependently restored the expression of ER but further downregulated that of ERß, indicating a differential regulation of ER isoforms.

Conclusions— Estrogenic control of iNOS was impaired in diabetic SMC. This was associated with a larger increase of ERß than of ER protein, whereas 17ß-estradiol regulated the two isoforms in an opposite fashion. Thus, modifications in the estrogen modulation of iNOS and in the expression pattern of ER may be involved in diabetic vascular dysfunction.

Key Words: myocytes • nitric oxide synthase • diabetes mellitus • hormones

This article has been cited by other articles:

				K. M. Gavin, D. R. Seals, A. E. Silver, and K. L. Moreau Vascular Endothelial Estrogen Receptor {alpha} Is Modulated by Estrogen Status and Related to Endothelial Function and Endothelial Nitric Oxide Synthase in Healthy Women J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3513 - 3520. [Abstract] [Full Text] [PDF]

				A. Cignarella, C. Bolego, V. Pelosi, C. Meda, A. Krust, C. Pinna, R. M. Gaion, E. Vegeto, and A. Maggi Distinct Roles of Estrogen Receptor-{alpha} and {beta} in the Modulation of Vascular Inducible Nitric-Oxide Synthase in Diabetes J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 174 - 182. [Abstract] [Full Text] [PDF]

				Y.-H. Chan, K.-K. Lau, K.-H. Yiu, S.-W. Li, H.-T. Chan, D. Y.-T. Fong, S. Tam, C.-P. Lau, and H.-F. Tse Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke Eur. Heart J., November 2, 2008; 29(22): 2800 - 2807. [Abstract] [Full Text] [PDF]

				C. Pinna, C. Bolego, P. Sanvito, V. Pelosi, R. Baetta, A. Corsini, R. M. Gaion, and A. Cignarella Raloxifene Elicits Combined Rapid Vasorelaxation and Long-Term Anti-Inflammatory Actions in Rat Aorta J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1444 - 1451. [Abstract] [Full Text] [PDF]

				C. Bolego, E. Vegeto, C. Pinna, A. Maggi, and A. Cignarella Selective Agonists of Estrogen Receptor Isoforms: New Perspectives for Cardiovascular Disease Arterioscler Thromb Vasc Biol, October 1, 2006; 26(10): 2192 - 2199. [Abstract] [Full Text] [PDF]

				R. C. Christian, P. Y. Liu, S. Harrington, M. Ruan, V. M. Miller, and L. A. Fitzpatrick Intimal Estrogen Receptor (ER){beta}, But Not ER{alpha} Expression, Is Correlated with Coronary Calcification and Atherosclerosis in Pre- and Postmenopausal Women J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2713 - 2720. [Abstract] [Full Text] [PDF]

				C. Bolego, A. Cignarella, P. Sanvito, V. Pelosi, F. Pellegatta, L. Puglisi, and C. Pinna The Acute Estrogenic Dilation of Rat Aorta Is Mediated Solely by Selective Estrogen Receptor-{alpha} Agonists and Is Abolished by Estrogen Deprivation J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1203 - 1208. [Abstract] [Full Text] [PDF]

				P. Y. Liu, R. C. Christian, M. Ruan, V. M. Miller, and L. A. Fitzpatrick Correlating Androgen and Estrogen Steroid Receptor Expression with Coronary Calcification and Atherosclerosis in Men without Known Coronary Artery Disease J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1041 - 1046. [Abstract] [Full Text] [PDF]

				F. Barchiesi, E. K. Jackson, B. Imthurn, J. Fingerle, D. G. Gillespie, and R. K. Dubey Differential Regulation of Estrogen Receptor Subtypes {alpha} and {beta} in Human Aortic Smooth Muscle Cells by Oligonucleotides and Estradiol J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2373 - 2381. [Abstract] [Full Text] [PDF]